Jeffrey Tyner, Ph.D.
- click here
"Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia,"
"Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia,"
"Corepressor Rcor1 is essential for murine erythropoiesis,"
"Functional genomics for personalized cancer therapy,"
"Functional integration of acute myeloid leukemia into the vascular niche,"